Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,531 | 18,576 | 9,055 | 5,468 | 6,767 |
| Marketable Securities | 66,206 | 158,018 | 152,992 | 169,571 | 143,434 |
| TOTAL | $153,270 | $177,095 | $162,584 | $175,705 | $150,970 |
| Non-Current Assets | |||||
| PPE Net | 765 | 819 | 873 | 923 | 945 |
| Investments And Advances | 29,594 | 25,101 | 56,373 | 53,465 | 3,531 |
| Other Non-Current Assets | 594 | 637 | 721 | 794 | 868 |
| TOTAL | $30,953 | $26,557 | $57,967 | $55,182 | $5,344 |
| Total Assets | $184,223 | $203,652 | $220,551 | $230,893 | $156,314 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,483 | 1,268 | 1,934 | 2,561 | 831 |
| TOTAL | $3,733 | $33,556 | $53,214 | $78,175 | $1,067 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 344 | 377 | 700 | 550 | 711 |
| TOTAL | $4,336 | $4,375 | $4,444 | $4,488 | $4,592 |
| Total Liabilities | $8,069 | $37,931 | $57,658 | $82,663 | $5,659 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,769 | 40,629 | 40,519 | 40,339 | 40,276 |
| Common Shares | 488 | 487 | 485 | 484 | 484 |
| Retained earnings | -146,808 | -156,020 | -157,556 | -170,892 | -167,670 |
| Other shareholders' equity | -911 | -918 | -928 | -902 | -891 |
| TOTAL | $176,154 | $165,721 | $162,893 | $148,230 | $150,655 |
| Total Liabilities And Equity | $184,223 | $203,652 | $220,551 | $230,893 | $156,314 |